BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35343383)

  • 1. The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling.
    Han D; Zhu S; Li X; Li Z; Huang H; Gao W; Liu Y; Zhu H; Yu X
    Cancer Biol Ther; 2022 Dec; 23(1):294-309. PubMed ID: 35343383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
    Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
    Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
    Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
    Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
    Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
    Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H
    Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of miR-125a-5p on Cell Proliferation,Apoptosis and Cell Cycle of Pancreatic Cancer Cells.
    Jia CW; Sun Y; Zhang TT; Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Aug; 38(4):415-21. PubMed ID: 27594154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB downstream miR-1262 disturbs colon cancer cell malignant behaviors by targeting FGFR1.
    Zhang W; Huang Z; Xiao Z; Wang H; Liao Q; Deng Z; Wu D; Wang J; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1819-1832. PubMed ID: 37867436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA SNHG4 modulates colorectal cancer cell cycle and cell proliferation through regulating miR-590-3p/CDK1 axis.
    Zhou Z; Tan F; Pei Q; Li C; Zhou Y; Li Y; Pei H
    Aging (Albany NY); 2021 Mar; 13(7):9838-9858. PubMed ID: 33744866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha.
    Huang F; Tang J; Zhuang X; Zhuang Y; Cheng W; Chen W; Yao H; Zhang S
    PLoS One; 2014; 9(2):e87897. PubMed ID: 24504166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
    DeArmond D; Brattain MG; Jessup JM; Kreisberg J; Malik S; Zhao S; Freeman JW
    Oncogene; 2003 Oct; 22(49):7781-95. PubMed ID: 14586404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
    Marin-Muller C; Li D; Bharadwaj U; Li M; Chen C; Hodges SE; Fisher WE; Mo Q; Hung MC; Yao Q
    Clin Cancer Res; 2013 Nov; 19(21):5901-13. PubMed ID: 23989979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of miR
    Liu Y; Hu Q; Ao J; Li H; Li M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):280-289. PubMed ID: 32386020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
    Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
    Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.
    Shukla K; Sharma AK; Ward A; Will R; Hielscher T; Balwierz A; Breunig C; Münstermann E; König R; Keklikoglou I; Wiemann S
    Mol Oncol; 2015 Jun; 9(6):1106-19. PubMed ID: 25732226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-301a as an NF-κB activator in pancreatic cancer cells.
    Lu Z; Li Y; Takwi A; Li B; Zhang J; Conklin DJ; Young KH; Martin R; Li Y
    EMBO J; 2011 Jan; 30(1):57-67. PubMed ID: 21113131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis.
    Zhu X; Niu X; Ge C
    Cancer Biol Ther; 2019; 20(6):799-811. PubMed ID: 30739523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling.
    Liang J; Liu Y; Zhang L; Tan J; Li E; Li F
    Chem Biol Interact; 2019 May; 304():1-9. PubMed ID: 30831090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.